| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Systemic Lupus Erythematosus | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Lupus Erythematosus, Systemic | |||||
| 3 | More general conditions related to this trial | ||||
| Autoimmune Diseases | |||||
| Connective Tissue Diseases | |||||
| Immune System Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| abatacept | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Prednisolone | |||||
| 6 | More general drug interventions related to this trial | ||||
| Anti-Inflammatory Agents | |||||
| Antineoplastic Agents | |||||
| Antineoplastic Agents, Hormonal | |||||
| Antirheumatic Agents | |||||
| Glucocorticoids | |||||
| Hormones | |||||
| Hormones, Hormone Substitutes, and Hormone Antagonists | |||||
| Immunologic Factors | |||||
| Immunosuppressive Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Bristol-Myers Squibb | |||||
|
